• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有重度或难治性哮喘的儿童及青少年的人口统计学和临床特征。

Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma.

作者信息

Chipps Bradley E, Szefler Stanley J, Simons F Estelle R, Haselkorn Tmirah, Mink David R, Deniz Yamo, Lee June H

机构信息

Capital Allergy and Respiratory Disease Center, Sacramento, CA 95819, USA.

出版信息

J Allergy Clin Immunol. 2007 May;119(5):1156-63. doi: 10.1016/j.jaci.2006.12.668. Epub 2007 Mar 30.

DOI:10.1016/j.jaci.2006.12.668
PMID:17397912
Abstract

BACKGROUND

Young patients with severe or difficult-to-treat asthma are an understudied population.

OBJECTIVE

To assess age-associated and gender-associated differences in children and adolescents in the observational study, The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens.

METHODS

Cross-sectional baseline data for patients greater than or equal to 6 years and less than or equal to 17 years (n = 1261) were stratified by age group (6-8, 9-11, 12-14, and 15-17 years). The chi(2) test for categorical variables and analysis of variance for continuous variables were used to identify differences among age groups, stratified by gender.

RESULTS

Most patients had moderate (55%) or severe (41%) asthma by physician assessment. Of those using greater than or equal to 3 long-term controllers (62%), 53% of children (6-11 years) and 44% of adolescents (12-17 years) reported an oral corticosteroid burst and 25% and 19%, respectively, had an emergency department visit in the previous 3 months; 10% and 15%, respectively, reported past intubation. In females, weight for age ranged between the 67th and 70th percentiles; height for age was between the 42nd and 54th percentiles (P < .01 among age groups). Lung function was lower in adolescents than children: prebronchodilator percent predicted forced expiratory volume in 1 second (FEV(1))/forced vital capacity was 0.92 (6-8 years) and 0.83 (15-17 years), P less than .05, in males; and 0.94 (6-8 years) and 0.87 (15-17 years), P less than .05, in females.

CONCLUSIONS

Children and adolescents demonstrated high rates of health care use and loss of lung function, despite using multiple long-term controllers.

CLINICAL IMPLICATIONS

Asthma treatments that prevent loss of lung function and reduce health care resource use are needed in young patients with severe or difficult-to-treat asthma.

摘要

背景

患有重度或难治性哮喘的年轻患者是一个研究不足的群体。

目的

在观察性研究“哮喘的流行病学和自然史:结局与治疗方案”中,评估儿童和青少年中与年龄和性别相关的差异。

方法

将年龄大于或等于6岁且小于或等于17岁(n = 1261)患者的横断面基线数据按年龄组(6 - 8岁、9 - 11岁、12 - 14岁和15 - 17岁)分层。使用分类变量的卡方检验和连续变量的方差分析来确定按性别分层的年龄组之间的差异。

结果

根据医生评估,大多数患者患有中度(55%)或重度(41%)哮喘。在使用至少3种长期控制药物的患者中(62%),53%的儿童(6 - 11岁)和44%的青少年(12 - 17岁)报告曾口服糖皮质激素冲击治疗,且在前3个月内分别有25%和19%的患者到急诊科就诊;分别有10%和15%的患者报告曾接受过插管治疗。女性的年龄别体重在第67至70百分位之间;年龄别身高在第42至54百分位之间(各年龄组间P <.01)。青少年的肺功能低于儿童:男性中,支气管扩张剂使用前1秒用力呼气容积(FEV₁)/用力肺活量预测值百分比在6 - 8岁时为0.92,在15 - 17岁时为0.83,P <.05;女性中分别为0.94(6 - 8岁)和0.87(15 - 17岁),P <.05。

结论

尽管使用了多种长期控制药物,但儿童和青少年的医疗保健利用率和肺功能丧失率仍很高。

临床意义

对于患有重度或难治性哮喘的年轻患者,需要有能预防肺功能丧失并减少医疗保健资源使用的哮喘治疗方法。

相似文献

1
Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma.患有重度或难治性哮喘的儿童及青少年的人口统计学和临床特征。
J Allergy Clin Immunol. 2007 May;119(5):1156-63. doi: 10.1016/j.jaci.2006.12.668. Epub 2007 Mar 30.
2
Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.哮喘的流行病学和自然史研究的设计与基线特征:结局与治疗方案(TENOR)研究:一大群重度或难治性哮喘患者
Ann Allergy Asthma Immunol. 2004 Jan;92(1):32-9. doi: 10.1016/S1081-1206(10)61707-3.
3
Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR.特诺儿童青少年研究中的过敏、总血清免疫球蛋白 E 和气流。
Pediatr Allergy Immunol. 2010 Dec;21(8):1157-65. doi: 10.1111/j.1399-3038.2010.01065.x.
4
Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma.阿司匹林敏感性与哮喘严重程度:重度或难治性哮喘患者存在不可逆性气道阻塞的证据。
J Allergy Clin Immunol. 2005 Nov;116(5):970-5. doi: 10.1016/j.jaci.2005.08.035. Epub 2005 Oct 3.
5
Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.一秒用力呼气容积百分比可改善哮喘儿童严重程度的分级。
Pediatrics. 2006 Aug;118(2):e347-55. doi: 10.1542/peds.2005-2962. Epub 2006 Jul 24.
6
Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.丙酸氟替卡松/昔萘酸沙美特罗氢氟烷计量吸入器在青少年和成年持续性哮喘患者中的耐受性:一项为期52周的开放标签、分层、平行组、多中心研究。
Clin Ther. 2007 Jul;29(7):1390-402. doi: 10.1016/j.clinthera.2007.07.021.
7
Gender differences in IgE-mediated allergic asthma in the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study.哮喘流行病学与自然史中IgE介导的过敏性哮喘的性别差异:结局与治疗方案(TENOR)研究
J Asthma. 2006 Apr;43(3):179-84. doi: 10.1080/02770900600566405.
8
Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma.一大群重度或难治性哮喘患者的血清总IgE水平。
Ann Allergy Asthma Immunol. 2005 Sep;95(3):247-53. doi: 10.1016/S1081-1206(10)61221-5.
9
Factors associated with the control of severe asthma.与重度哮喘控制相关的因素。
J Asthma. 2010 Mar;47(2):124-30. doi: 10.3109/02770900903518835.
10
Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study.老年哮喘:来自哮喘流行病学与自然史:结局与治疗方案(TENOR)研究的观察结果
Ann Allergy Asthma Immunol. 2006 Mar;96(3):406-14. doi: 10.1016/S1081-1206(10)60907-6.

引用本文的文献

1
Epidemiology of severe asthma in children: a systematic review and meta-analysis.儿童严重哮喘的流行病学:系统评价和荟萃分析。
Eur Respir Rev. 2024 Oct 9;33(174). doi: 10.1183/16000617.0095-2024. Print 2024 Oct.
2
Prediction of Asthma Exacerbations in Children.儿童哮喘急性发作的预测
J Pers Med. 2023 Dec 22;14(1):20. doi: 10.3390/jpm14010020.
3
Pyrroloquinoline Quinone Administration Alleviates Allergic Airway Inflammation in Mice by Regulating the JAK-STAT Signaling Pathway.吡咯并喹啉醌给药通过调节 JAK-STAT 信号通路缓解小鼠过敏性气道炎症。
Mediators Inflamm. 2022 Oct 29;2022:1267841. doi: 10.1155/2022/1267841. eCollection 2022.
4
Efficacy, safety, and tolerability of lebrikizumab in adolescent patients with uncontrolled asthma (ACOUSTICS).莱布立izumab治疗未控制哮喘青少年患者的疗效、安全性及耐受性(ACOUSTICS研究)
Clin Transl Allergy. 2022 Jul 14;12(7):e12176. doi: 10.1002/clt2.12176. eCollection 2022 Jul.
5
Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) in Pediatric Severe Allergic Asthma-A Romanian Perspective.抗IgE单克隆抗体(奥马珠单抗)治疗儿童重度过敏性哮喘的临床经验——罗马尼亚视角
Children (Basel). 2021 Dec 6;8(12):1141. doi: 10.3390/children8121141.
6
A territory-wide study on the factors associated with recurrent asthma exacerbations requiring hospitalization in Hong Kong.一项关于与香港需要住院治疗的复发性哮喘加重相关因素的全港性研究。
Immun Inflamm Dis. 2021 Jun;9(2):569-581. doi: 10.1002/iid3.419. Epub 2021 Mar 3.
7
Enhanced airway hyperresponsiveness in asthmatic children and mice with A(H1N1)pdm09 infection.甲型 H1N1 流感病毒感染致哮喘患儿及小鼠气道高反应性增强。
Immun Inflamm Dis. 2021 Jun;9(2):457-465. doi: 10.1002/iid3.406. Epub 2021 Jan 20.
8
Spasm Provocation Test Using Acetylcholine in Patients with Bronchial Asthma: An Important Step Forward.支气管哮喘患者使用乙酰胆碱的痉挛激发试验:向前迈出的重要一步。
Intern Med. 2020 Dec 15;59(24):3115-3116. doi: 10.2169/internalmedicine.5568-20. Epub 2020 Aug 12.
9
Monitoring of omalizumab therapy in children and adolescents.儿童和青少年中奥马珠单抗治疗的监测
Allergol Select. 2018 Sep 1;2(1):32-38. doi: 10.5414/ALX01337E. eCollection 2018.
10
Severe Asthma-Perspectives From Adult and Pediatric Pulmonology.重度哮喘——成人与儿童肺病学视角
Front Pediatr. 2019 Oct 9;7:389. doi: 10.3389/fped.2019.00389. eCollection 2019.